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N
anotechnology is rapidly evolving
from the discovery phase to the
application phase. As a result,
nanomaterials are being distributed in articles
of commerce. Although assessments of the
hazards of speciﬁc nanomaterials have
failed to keep pace with the introduction
of new materials, some general themes
have begun to emerge. For instance, parti-
cles of similar core composition appear to
behave similarly, and general axioms have
been proposed regarding the eﬀect of
particle size and charge on biological
interactions.
14 For example, it has been
proposed that positively charged particles
are more likely to be toxic than negative or
neutral particles, and smaller particles are
generally more toxic per mass-based con-
centration than larger particles.
1,2 Further
development and reﬁnement of these ax-
ioms, coupled with rapid screening assays
that forecast environmental and health im-
pacts,canbecombinedwiththeimplemen-
tation of green chemistry principles (atom
economy, solvent reduction, catalysis, de-
signed benign degradation in the environ-
ment, avoidance of known toxic hazards
in synthesis, etc.)
5 to fuel safer design of
future nanomaterials and nanomanufactur-
ing processes.
6,7 Such proactive approaches
to reducing environmental impact and de-
termining potential adverse eﬀects of nano-
materials will help save signiﬁcant resources
by quickly removing particles with undesir-
able qualities from the development pipeline.
A signiﬁcant amount of data on nanoma-
terialbiological interactions exists; how-
ever, no consensus has been gained on
the appropriate test methods (assays) to
evaluate biological eﬀect or toxicity, on
the relative inﬂuence that physicochemical
properties have on nanoparticle eﬀects, or
on the fundamental principles that govern
nano/biointeractions. The nearly unlimited
variations in the elemental composition,
core size, surface functionalization, purity,
and synthesis methods suggest that the
independent testing of every variation is
neither feasible nor desirable. Instead, the
relative inﬂuencethatspeciﬁcnanomaterial
features haveon biological interactions and
responses should be deﬁned in order to
create a framework of structureactivity
relationships. For the diﬀerent classes and
permutations of nanomaterials these rela-
tionships will enable informed design of
new nanomaterials. A systematic approach
to isolating the eﬀects of individual nano-
material features on these interactions
would yield more informed rules for safer
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ABSTRACT The challenge of optimizing both performance and safety in nanomaterials hinges
on our ability to resolve which structural features lead to desired properties. It has been diﬃcult to
draw meaningful conclusions about biological impacts from many studies of nanomaterials due to
the lack of nanomaterial characterization, unknown purity, and/or alteration of the nanomaterials
by the biological environment. To investigate the relative inﬂuence of core size, surface chemistry,
andchargeonnanomaterialtoxicity,wetestedthebiologicalresponseofwholeanimalsexposedto
amatrix ofnine structurally diverse, precision-engineered goldnanoparticles (AuNPs)ofhigh purity
and known composition. Members of the matrix include three core sizes and four unique surface
coatings that include positively and negatively charged headgroups. Mortality, malformations,
uptake, and elimination of AuNPs were all dependent on these parameters, showing the need for
tightly controlled experimental design and nanomaterial characterization. Results presented herein
illustrate the value of an integrated approach to identify design rules that minimize potential
hazard.
KEYWORDS: uptake . biocompatibility . toxicity . nanotoxicology .
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nanoparticle design and synthesis. The ideal metho-
dology would probe the nanomaterialbiological in-
teractions using a high-throughput, sensitive, in vivo
biological assay that minimizes false negatives. A
reasonable course of actionwould betosystematically
probe potential structureactivity relationships within
eachclassofnanoparticles,withthehopethatperhaps
some ﬁndings would be more generalizable. The key
to being successful in this undertaking is precision
engineering of the nanomaterials, with systematic
variation of the physicochemical properties and full
characterization of the nanomaterials. This precision
matrix of nanomaterials must then undergo biological
assessment via a high-sensitivity, high-content, and
high-throughput assay that is capable of increasing
understanding of how both doseresponse and
uptakeelimination aﬀect nano/biointeractions. We
present such a platform here for gold nanoparticles,
utilizing a matrix of well-characterized spherical gold
nanoparticles (AuNPs) and the embryonic zebraﬁsh
assay.
A Gold Standard for Investigating Size and Ligand Effects
of Nanomaterials in vivo. Of the nanomaterials known
today, AuNPs represent the ideal platform for system-
atically assessing the influence of various physico-
chemical parameters (within the class of gold nano-
particles) on biological responses to nanomaterial
exposure.
8 The synthesis of AuNPs can be controlled
so that individual aspects of the material, i.e., size,
shape, purity, and surface functionalization, can be
altered systematically and independently.
914 Com-
prehensive characterization and purification methods
for AuNPs have been established and validated.
15,16
AuNPs described here are soluble (or remain indefi-
nitely suspended) in aqueous media, and similar com-
positions are being designed and tested for many
medical applications.
17,18 Most importantly, AuNP
dose can be quantified within complex biological
matrixes with very high accuracy and sensitivity using
a variety of methods, including INAA
19 and ICP-MS.
20
Due to the surge of interest in AuNPs for basic
research and for novel biomedical applications, more
insight into how AuNPs interact with biological sys-
tems is needed. Gold nanoparticles show great pro-
mise as therapeutics and therapeutic delivery vectors,
as sensing and imaging agents, as photocatalysts, and
as chemical detectors in home pregnancy tests and
lung-cancer diagnostics.
2123 To successfully and
safely advance such technologies requires a funda-
mental understanding of how nanomaterials interact
with biological systems.
24
Here, we tested a matrix of precision-engineered
AuNPs to determine the eﬀects of core size, surface
functionalization, and charge on uptake rates and the
biological consequences of exposure (Figure 1). Func-
tionalized nanoparticles were synthesized from initial
coresizesof0.8,1.5,and15nm.Fourligandtypeswere
tested that varied in length and were either positively
charged, negatively charged, or neutral. MEE is a
neutral ligand possessing two ethylene glycol units
and a terminal methoxy group; MEEE has an extra
ethoxy group added to increase the solubility of the
neutral AuNPs and to test the eﬀect of ligand length.
TMAT isa positively charged (cationic) ligand, andMES
is a negatively charged (anionic) ligand. Each ligand is
tightly bound to the nanoparticle surface through a
gold thiolate linkage. The number of ligands shown in
Figure 1c for the 0.8 and 1.5 nm AuNP was determined
empirically,
9,10 while the number of ligands for the
15nmAuNPwascalculatedonthebasisofanaccepted
approach in the literature.
25 Testing the various com-
binations of these core sizes and ligand shells allowed
us to investigate the signiﬁcance of small changes in
core size and ligand composition independently.
AuNPs were rigorously puriﬁed by diaﬁltration to
remove small ligand impurities and characterized by
TEM,
1H NMR, UVvis, and measuring the zeta poten-
tial of AuNPs in reverse osmosis (RO) water and ﬁsh
water(ROwaterplus0.6%InstantOcean)(seeSupport-
ing Information Figures S1S4).
We chose to investigate very small (<2 nm) AuNPs
in addition to the more common 15 nm AuNPs for
several reasons. The small AuNPs show commercial
potential for catalysis and nanoelectronics
18,2628 and
as biological tags for diagnostic applications. Such
small nanoparticles are nearly always present and
often undetected in samples of larger particles,
16 thus
making them of particular interest for research on
environmental health and safety (nanoEHS). The small
Figure 1. Gold nanoparticle synthesis, structure, and
properties. (a) Synthesis reaction of functionalized gold
nanoparticles from gold triphenylphosphine (AuTTP)nano-
particlebuildingblocks.(b)Charge,structure,andnameare
given for each ligand tested. (c) Various properties with
implications for dose metrics for the diﬀerent nanoparticle
core sizes are given.
A
R
T
I
C
L
EHARPER ET AL.V O L . 5 ’ NO. 6 ’ 4688–4697 ’ 2011
www.acsnano.org
4690
particles in those samples are typically the byproduct
of a bottom-up synthesis process or the products of
degradation of larger particles upon interaction with
the environment or biological systems.
An important distinction should be drawn between
the AuNPs assessed here and previous investigations
of size- and ligand-dependent eﬀects of AuNPs.
2931
Previous investigations have used either phosphine-
linked ligands, which are easily substituted by other
groups in physiological conditions, including direct
binding of the gold core to DNA via substitution of
the phosphine ligand,
2931 or citrate-stabilized nano-
materials,
32whichareeasilysubstitutedwithbiological
molecules, tend to aggregate upon exposure to salt,
and lack a well-deﬁned ligand shell environment. In
most practical applications, AuNPs would be func-
tionalized in a more irreversible manner in order to
preserve their desired activity and stability. In this
study, all ligands were ﬁrmly anchored to the gold
core,
15 making a more accurate assessment of the
eﬀectofligandonAuNPtoxicitypossible(seeSupport-
ing Information Figure S2).
RapidPlatformtoInterrogateNanobiologicalInteractionand
Responses in Embryonic Zebrafish. Biological testing of
nanomaterials was performed using the embryonic
zebrafish as a dynamic whole animal assay because
they are logistically attractive for rapidly evaluating
integrated system effects, are sensitive indicators of
adversebiologicalinteractions,andareanoutstanding
platform to define the mechanism of action when
deleterious effects are elicited from exposure.
24,33
Zebrafish have remarkable similarity in molecular sig-
naling processes, cellular structure, anatomy, and phy-
siology to other high-order vertebrates including
humans.
3436 Fundamental processes of vertebrate
development are highly conserved across species,
making translation of observations to humans or other
vertebrates less problematic than adult rodentstudies.
In addition, early development offers us the only
“windowofopportunity”inwhichallgeneralmolecular
signaling pathways are both necessary and active.
Testing during this critical period allows us to cast a
wide net, identifying any nanomaterials that interact
with key biomolecules and/or signaling pathways es-
sential for other cells and tissues later in life.
37 Since
highly coordinated cell-to-cell communications and
molecular signaling are required for normal develop-
ment, if nanomaterials perturb these interactions, de-
velopment would likely be disrupted. Perturbed
development can manifest as morphological malfor-
mations, behavioral abnormalities, or death of the
embryos. Zebrafish embryos are especially ideal for
high-throughputscreeningduetotheirexternaldevel-
opment, optical transparency, short breeding cycle,
and reduced husbandry costs.
38
Zebraﬁsh have long been a well-established model
for studying developmental biology and have recently
been employed to investigate how nanomaterials
interact with complex biological systems
24,33,39,40 as
well as the toxicity and eﬃcacy of chemicals, pharma-
ceuticals, and pesticides.
34,36 The experimental design
tests for nanomaterial toxicity during early vertebrate
development for two important reasons. First, funda-
mental processes of development are highly con-
served across species.
41 Second, vertebrates at
the earliest life stages are often more responsive
to perturbation.
37
During the time frame of the screening assay
(0120 hpf (hours postfertilization)), oxygen is primar-
ily supplied to the embryo via diﬀusion across the
skin, which is also a major route of absorption of
chemicals.
42,43Zebraﬁshlarvabegintoswallowaround
72 hpf, making oral exposure a possibility as well. Gill
development is not complete until almost 2 weeks
after fertilization.
44 The embryonic zebraﬁsh platform
therefore combines the beneﬁt of the total saturation
with the compound in question found in in vitro
studies with the sensitivity aﬀorded by the whole
organism used with in vivo interrogation during this
critical period of development. This approach max-
imizes bioavailability due to the saturation of the
embryo (which is essentially a sponge at the critical
stages tested) with the compound in question.
Finally,assayvolumesusingthezebraﬁshmodelare
small, so only limited amounts of well-characterized
nanomaterials are needed to assess nanomaterial
biological interactions. Nanomaterial availability at
suﬃcient quantities to perform equivalent rodent
studies remains a barrier at the present time. In es-
sence,theembryoniczebraﬁshmodeloﬀersthepower
of whole-animal investigations (e.g., intact organism,
functional homeostatic feedback mechanisms, and
intercellular signaling) with the convenience of cell
culture (e.g., cost- and time-eﬃcient, minimal infra-
structure, small quantities of nanomaterial solutions
required). The integrated approach to nanomaterial
design and biological assessment presented here is
illustrated in Figure 2.
Nanomaterial Testing Paradigm to Evaluate Toxic Potential.
To evaluate our highly purified, well-characterized
matrix of AuNPs for biological activity and toxic poten-
tial,embryoniczebrafishwerecontinuouslyexposedin
water for 5 days (covering gastrulation through
organogenesis) to a wide range (0.016250 ppm) of
AuNP concentrations and evaluated for developmen-
tal, morphological, and behavioral effects. Since nor-
mal development requires highly coordinated cell-to-
cellcommunications,nanomaterialsthatperturbthese
interactions should result in changes in embryo mal-
formations and/or mortality.
The nanoparticle concentrations we tested are pre-
sented in mass/volume (g/L) based parts-per-million
(ppm) units in order to provide ease of comparison
withotherstudies,asitisthedefactounitintoxicology.
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Such weight-based measurements are likely to be
applied in industrial and commercial applications.
However, the large diﬀerences in molecular weight
and surface area between the diﬀerent nanomaterials
tested have interesting implications for the interpreta-
tionofthedata,asitpertainstothediﬀerentialeﬀectof
particle size, which we will address in the discussion.
RESULTS
Biological ImpactsofAuNP Exposure. Exposure toAuNPs
affected mortality and/or the incidence of mal-
formations primarily in a charge-dependent manner
(Figure 3). Since the embryonic zebrafish assay is a
screening-level assay, sublethal malformations are just
as important as mortality, because we are assessing
only adverse impacts on an important pathway, not
how that pathway might affect health. Structure
activityrelationshipsfornanomaterialscanbedeveloped
by first “binning” nanomaterials into having an “effect”
or “no effect” in the embryonic zebrafish assay, then
probing the details of the interaction for those nano-
materialsthatdoshowaneffect.Fisher'sexacttestwas
selected for statistical evaluation because the data are
categorical:thereiseitheran“effect”or“noeffect”.This
statistic is conservative and allows for the direct com-
parison of the number of instances an effect was
observed in treated versus untreated animals.
45 The
mostsensitivemeasurementofnanomaterialtoxicityis
the combined incidence of mortality and malforma-
tions, shown in Figure 3a. Malformations typically
included the heart, eyes, body axis, jaw, trunk, and
fins.Examplesofcommonmalformations areshownin
Figure 3b.
Exposure to positively charged TMAT-AuNPs sig-
niﬁcantly increased mortality (Figure 3c), but had a
negligibleeﬀectonmalformations(Figure3d).Negatively
Figure 2. Overview of structureactivity investigation of gold nanoparticles. Ligands to be tested are selected from a large
library of possible functional groups. Combining these ligands with well-characterized, high-purity AuNPs of diﬀerent sizes
allows the isolation of size and ligand as variables in gold nanotoxicity. After exposure to nanomaterials, zebraﬁsh are
screenedformortality,morphology,andbehavioralchanges,aswellashavinguptakeandeliminationofAuNPsquantiﬁedby
INAA. These results inform the selection of new ligands and particle sizes for assessment.
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chargedMES-AuNPssigniﬁcantlyincreasedtheincidence
of malformations but did not result in signiﬁcant lethality
within the ﬁve-day exposure period. Malformations re-
sultingfromexposureto1.5nmMES-AuNPsincludedthe
j a w ,e y e s ,s n o u t ,h e a r t ,a n dﬁns. For the 0.8 nm MES-
AuNPs, exposure at 250 ppm resulted in jaw malfor-
mations and an unusual mass on the body trunk in
100% of embryos. Cellular level investigations re-
vealed that this mass was due to overproliferation
of the notochord cells within the ﬁrst 2448 h that
later protrudes and manifests as an external mass
(Supporting Information Figure S5).
NeutralMEE-AuNPsandMEEE-AuNPsdidnotelicit
any adverse eﬀects even at concentrations up to 250
ppm (ppm), an extremely high exposure concentra-
tion. The gold salt used in nanoparticle synthesis
(PPh3AuCl) and all of the individual ligands were also
tested and had no eﬀect on malformations or mor-
tality at concentrations up to 250 ppm. It should be
noted that this concentration is equivalent to the
entire AuNP being made up of ligand (or gold salt)
andisthereforemanyordersofmagnitudehigheron
a molar basis than the number of ligands associated
with the AuNPs or present as impurities in AuNP
exposure groups.
TheTMATparticlesappeartoexhibitatrendtoward
smaller sized particles being more toxic, and it also
would appear that the 15 nm AuNPs were relatively
benign. However, calculating dosimetry for nanoma-
terials can be a tricky business, and it has been
suggested that concentrations based on total surface
area or number of particles per unit volume may be
more informative than the traditional mass/volume
units that are designed for bulk materials.
46 When
the doseresponse curve is drawn using particles/L
as the metric, the trend toward small particles being
more toxic is reversed, and when the exposure con-
centrationsareexpressedasavailablesurfacearea(nm
sq), the doseresponse curves for all the particle sizes
are almost identical (see Supporting Information Fig-
ure S6).
The results of this study demonstrate the utility of
an integrated approach to quickly determine whether
a member of the AuNP matrix tested can be “binned”
ashavingan“eﬀect”or“noeﬀect”basedonthecharge
of the attached ligand. Both positively and negatively
Figure 3. Doseresponse results of embryonic zebraﬁsh screen for tested AuNPs. (a) Percentage of zebraﬁsh exhibiting
eithermortalityoranymalformationforeachsizeandligandtestedacrossaspectrumofconcentrationscomparedtocontrol.
(b) Examplesof malformations seen uponexposure to 0.8 nm MES-AuNPs scored in the malformation categorycompared to
0 ppm control embryo. (c) Percentage of zebraﬁsh dying after exposure to the library of AuNPs. (d) Percentage of zebraﬁsh
that survive, but showing some malformation or behavioral abnormality. Signiﬁcance was determined by the Fisher exact
test, *p < 0.05, **p < 0.01 compared to control.
A
R
T
I
C
L
EHARPER ET AL.V O L . 5 ’ NO. 6 ’ 4688–4697 ’ 2011
www.acsnano.org
4693
charged AuNPs cause an eﬀect, and both neutral
AuNPs tested show no eﬀect. A closer examination
of the data reveals that TMAT-AuNPs primarily
caused mortality, whereas exposure to MES-AuNPs
generally resulted in malformations. This diﬀerence
could be due to diﬀerent mechanisms of interac-
tion, diﬀerential uptake, or diﬀerential elimination
of the AuNPs. In order to investigate the latter two
possibilities, we quantiﬁed uptake and elimination
of AuNPs.
Nanomaterial Uptake and Elimination Profiles. Character-
izationtechniquessuchasNMR,UVvis,orTEMdonot
provide critical information on the uptake and dose of
AuNPs. In order to accurately relate exposure-to-dose
to effects, instrumental neutron activation analysis
(INAA) was used to quantify the amount of Au in, or
tightly associated with, individual embryonic zebrafish
exposed to AuNP solutions. One of the benefits of the
embryonic zebrafish screen is that it is a vertebrate
exposure system where many of the variables con-
cerning different routes of exposure have been simpli-
fied or eliminated. As mentioned previously, gill
formation does not occur until after the exposure
period tested here, and oral uptake is not a significant
route of exposure until at least 72 h. Tests to establish
the “critical window” of exposure to the toxic AuNPs
haveshownthatmalformationsand/ormortalityoccur
at the same rate even if embryos are exposed to the
AuNPs only from 0 to 48 hpf, when the only route of
exposure is epithelial.
47 While no screening platform is
perfect, as illustrated by the fact that uptake can be
variable even in cell culture exposures to nano-
materials,
46 every effort has been made to ensure that
bioavailability is maximized in this system.
Embryonic zebraﬁsh were exposed to 0.8 or 1.5 nm
MEE-, MEEE-, and MES-AuNPs at 50 ppm or 0.8, 1.5, or
15 nm TMAT-AuNPs at 0.4 ppm, and INAA was per-
formed at 24, 48, and 120 h postfertilization (hpf).
TMAT-AuNPs had to be tested at the lower concentra-
tion due to early mortality at higher doses. These
values were chosen to determine the uptake and
elimination of AuNPs at the EC50 dose of each AuNP
tested. More comprehensive studies of uptake com-
paring diﬀerent AuNPs across a variety of time points
and concentrations are currently being undertaken,
but are beyond the scope of this paper.
All AuNPs tested showed sustained or increased
uptake from 24 to 48 hpf (Figure 4a). However, be-
tween48and120hpf,theparticlesbehaveddiﬀerently
depending on surface charge. For the negatively
charged MES-AuNPs, the quantity of Au increased
signiﬁcantly (p < 0.05) over the ﬁrst two days, then
signiﬁcantly decreased (p < 0.01) to a negligible level
by ﬁve days. For neutrally charged AuNPs (MEE and
MEEE), the majority of Au wastaken into the system by
24 hpf, remained steady through 48 hpf, and was
completely cleared by the ﬁve-day mark, similar to
the MES-AuNPs. In contrast, TMAT-AuNP uptake was
sustained or increased across the whole time course.
The quantity of Au accumulated from exposure to
1.5nmTMAT-AuNPswassigniﬁcantlyincreasedbyﬁve
days over the values observed at 24 and 48 h. AuNPs
functionalized with TMAT had the highest uptake as a
percent of Au in the exposure solution, but due to the
diﬀerence in exposure concentration, the loading of
the actual number of nanoparticles in ﬁsh exposed to
MEE, MEEE, and MES AuNPs was higher by at least an
order of magnitude at the 24 and 48 hpf time points
(see Table 1).
Theuptake rates ofTMAT-AuNPs cannotbedirectly
compared to the other AuNPs since exposure concen-
trations had to be reduced due to the mortality
observed at higher concentrations. The toxicity of
these positively charged AuNPs might be reﬂective of
their preferential uptake into the animals. Uptake
kinetics revealed that AuNPs taken up within the ﬁrst
2448 h were eliminated by 120 hpf for neutral and
negatively charged AuNPs (Figure 4b). Elimination of
Figure 4. Quantiﬁcation by INAA of gold in zebraﬁsh em-
bryos exposed to AuNPs. (a) Instrument neutron activation
analysis was used to quantify the mass of Au in individual
embryos (N = 3) exposed to 0.8, 1.5, or 10 nm AuNPs. The
eﬀect of exposure duration on bioaccumulation of Au was
tested using ANOVA (**p < 0.001, *p < 0.05). Where sig-
niﬁcant diﬀerences were identiﬁed, pairwise comparisons
were performed using the Tukey test. Dunn's ANOVA test
on ranks was used when equal variance assumptions were
violated. (b) Uptake and elimination rates for AuNPs in
embryonic zebraﬁsh. Rates were calculated as the mass of
gold (ng) divided by the duration (hours) for embryos
exposedto50ppmAuNPsfunctionalizedwithMEE,MES,or
MEEEand 0.4ppmAuNPsfunctionalizedwithTMAT.Values
above the line indicate uptake, and values below the line
indicate elimination.
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AuNPs from the embryos appears to coincide with
maturationoftheliverandpronephrose(kidney)by50
and 72 hpf, respectively.
48,49 Zebraﬁsh exposed to the
1.5 nm MEE-AuNPs began elimination in as little as
48 hpf. By 120 hpf, less than 5 ngof gold was observed
in the samples for all but the TMAT-AuNPs, suggesting
thateliminationprocessesfortheneutralandnegative
particles are more eﬃcient than uptake and/or the
AuNPs left in solution after that time are not readily
bioavailable.TheTMAT-AuNPseitherwereneverelimi-
nated after the initial uptake or are continuously
replaced at the same or faster pace than they can be
eliminated. The fact that the majority of zebraﬁsh
exposedtoTMAT-AuNPsinthedoseresponseexperi-
mentsdiewithintheﬁrst24hoftheexperimentaltime
course would suggest that the former explanation is
more likely.
These uptake data imply that biological systems
react to positively charged nanoparticles diﬀerently
thanothernanomaterialsandsuggestthatAuNPswith
MES and TMAT ligands act through fundamentally
diﬀerent mechanisms, since TMAT-AuNPs cause pri-
marily mortality at low doses and are not readily
eliminated by the organism, while MES can be toler-
ated at higher concentrations, is rapidly cleared from
the animal, and manifests its biological eﬀect through
malformations rather than mortality.
DISCUSSION
The embryonic zebraﬁsh assay revealed that gold
nanoparticles with no charge do not adversely impact
biologicalsystemsacrossabroadrangeofsizes.AuNPs
with both positive and negative charges perturbed
development signiﬁcantly, with positively charged
AuNPs primarily causing mortality and negatively
charged particles inducing malformations. The zebra-
ﬁsh embryos took up all AuNP types tested, but TMAT-
AuNP particles were not eliminated as rapidly as the
MES-, MEE-, and MEEE-AuNP particles.
While the results demonstrate the importance of
charge on AuNPs' interactions with biological systems,
the question of the importance of size raises many
issues that require consideration. Most important to
considerations of size is the metric used to quantify
exposure concentrations. At least in the case of the
TMAT AuNPs in this study, diﬀerent metrics suggested
diﬀerent conclusions on the impact of size on toxicity.
As shown in Supporting Information Figure S6, one
could interpret smaller TMAT-AuNPs as being more
toxic (ppm) and larger as more toxic (molarity) or
conclude that size does not impact toxicity (surface
area), depending on the metric used. From a practical
standpoint, while mass-based measurement will prob-
ably continue to be the standard in applied uses of
nanomaterials,perhapstherelationshipbetweenmass
and surface area could be exploited to oﬀer some
predictions on the behavior of nanomaterials of diﬀer-
ent sizes.
Ifsurfaceareaisindeedthemostrelevantparameter
regarding size, this also could suggest some hypoth-
eses for the mechanism of AuNP eﬀects, namely, that
the interaction is with the ligand attached to the core
surface or the core surface itself. Alteration of cellular
binding protein systems or cellular redox changes are
two potential routes of action that would be surface-
area dependent.
When interactions take place on the nanometer
scale, small changes in nanomaterial properties can
result in large diﬀerences in biological response. While
surface chemistry appeared to have the most drastic
inﬂuence on AuNPs' behavior in our biological test
system, the data could also be interpreted to suggest
that AuNP behavior is modulated by core size. Our
research strategy couples the many advantages of the
whole-animal embryonic zebraﬁsh assay with an ideal
nanoparticle platform in order to systematically assess
t h er e l a t i v ei n ﬂuence of various physicochemical param-
eters on overall biological responses to nanomaterial
TABLE 1. Raw Data for Quantity of AuNPs Found in Embryonic Zebrafish As Determined by INAA
a
quantiﬁcation of Au in ng
(% of available) mean number of AuNPs
surface groups core size (nm) ng Au avail. 24 hpf 48 hpf 120 hpf 24 hpf 48 hpf 120 hpf
MEE 0.8 2.2 10
4 50(2(0.23) 70( 5(0.31) 0(0) 1.4 10
13 1.9 10
13 0.0
1.5 2.9 10
4 187( 29(0.65) 141(37(0,49) 3( 4(0.01) 5.7 10
12 4.3 10
12 9.1 10
10
MES 0.8 3.2 10
4 94(52(0.29) 190 ( 20(0,59) 0(0) 2.6 10
13 5.3 10
13 0.0
1.5 4.2 10
4 113(13(0.27) 324 (35(0,76) 4(1(0.01) 3.4 10
12 9.8 10
12 1.2 10
11
MEEE 0.8 2.3 10
4 102(60(0.44) 150 ( 31(0.65) 3(4(0.01) 2.8 10
13 4.2 10
13 8.3 10
11
1.5 2.5 10
4 74(12(0.29) 84( 5(0.34) 1(0(0.01) 2.2 10
12 2.5 10
12 3.0 10
10
TMAT 0.8 2.8 10
1 6.8(3.0(24.46) 7,6 ( 1.2(27.60) 5.7(0.6(20,59) 1.9  10
12 2.1 10
12 1.6 10
12
1.5 3.3 10
1 5.2(0.7(16.06) 5.8 ( 0.4(17.72) 11.1(3(34,39) 1.6 10
11 1.8 10
11 3.4 10
11
10 3.8 10
1 1.2(0.2(3.12) 2.2 (0.3(5.83) 1.7(0.6(4.5) 9.9 10
7 1.8 10
8 1.4 10
8
aThedatapresentedinthistableshowthatwhilethetotalquantityofTMAT-AuNPstakenupbytheembryoswasquitesmall,itwasbyfarthegreatestuptakecomparedto
other ligands as a percentage of total available AuNPs in the exposure.
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exposure. Deﬁning the structural characteristics that
biologically active (beneﬁcially or adversely) nanoma-
terials possess is essential to identifying features that
are predictive of biological responses and consequen-
tially the material modiﬁcations that can minimize
hazard.
24,50
METHODS
Nanoparticle Synthesis. The precision-engineered nanoparti-
cles used in these studies were prepared using methods
modified from the literature. For the preparation of the 0.8
and 1.5 nm particles, phosphine-stabilized particles were first
prepared using literature procedures.
51,52 These products serve
as intermediates for producing the particles with different
surface chemical functionalities through established ligand
exchangeprocedures.Theligandexchangeprocedureemploys
thiols to selectively replace both the PPh3 and Cl surface
groups.
9,10
TMAT-stabilized 15 nm AuNPs were prepared by ligand
exchange of citrate-stabilized gold nanoparticles that were
synthesized via an adaptation of the method reported by
Turkevich
53 and had excess citrate removed by diaﬁltration. A
20-fold excess of N,N,N-trimethylammoniumethanethiol iodide
was used during the exchange.
As a ﬁnal step, excess ligand and reaction byproduct were
removed to ensure product purity and long-term stability.
Diaﬁltration was used to purify water-soluble AuNPs (i.e., those
with a water-soluble ligand shell). The 1.5 nm particles are most
eﬀectively puriﬁed using a membrane rated for 10000 Da,
which corresponds to an approximate pore size of 78 nm.
Particles on the order of 815 nm require membranes rated for
70100 kDa molecules or 5080 nm.
The 0.8 and 1.5 nm AuNPs are soluble in aqueous solutions
for months, as determined by their stable UV spectra over that
time span and the inability to clear the solution through
centrifugation. The 15 nM AuNPs could be characterized as a
stable suspension, as they can be pelleted with centrifugation,
unlike the smaller AuNPs.
AuNP Characterization. The following methods were used to
characterize AuNPs. TEM was utilized to characterize the purity
and size distribution of the AuNPs. Optical spectra (UVvis)
werecollectedandzetapotentialmeasurementsweremadeon
solutions of nanoparticles.
1H NMR was used to assess the
presence of free ligand, unwanted byproduct, and excess
reactants. NMR was performed on a Varian INOVA 300 NMR
spectrometer.NMRsampleswerepreparedbydissolving10mg
ofsamplein2mLofCD2Cl2inaglassNMRtube.TheligandNMR
shows significant broadening when associated with the AuNPs,
so it is relatively simple to detect the presence of free ligand.
UVvis was used to qualitatively assess the size of the AuNPs
(particles greater than 2 nm show plasmon absorption at
520 nm). UVvis was performed on an Ocean Optics spectro-
meterusingaquartzcuvette toensure thatabsorption downto
200 nm could be obtained. The AuNPs dissolved in CH2Cl2were
added dropwise to the cuvette (filled with CH2Cl2). Absorption
spectra were recorded when the maximum absorption reached
2 on the relative scale. TEM was used to directly image the
particlesanddeterminetheirsizeandsizedistribution.TEMwas
performed on a Philips CM-12 120 keV transmission electron
microscope. Samples were prepared by aerosol spray deposi-
tion onto SiO2/Si grids produced by Dune Sciences (Eugene,
OR). Particle size analysis
54 was conducted using ImageJ soft-
ware from the NIH Web site.
For testing of zeta potential, dry nanoparticles were dis-
solvedinROorﬁshwaterspeciﬁedtocontainnoparticleslarger
than 5 nm. Each of the samples (which were of various weights)
was suspended in 1 mL, and then a 1:100 dilution was taken.
This brought the particles into the lower threshold of the ppm
range (and the preferential range for the ZetaPALS system)
between 2.5 and 9 ppm. Each sample was vortexed for 10 s,
inverted three times, then vortexed again for 10 more seconds
before and after mixing, transfer, or dilution. Transfer, dilution,
and mixing were alldone withina minute ofvortexing;samples
were read by the machine within 5 min of vortexing. All
containers received at least a triple rinse with the above-
mentioned RO water. Zeta potential electrodes were rinsed
with corresponding sample before measurement. Ten runs of
20 cycles were used for samples; 5 runs of 10 cycles for blanks.
Zeta potential was calculated from mobility under the Smolu-
chowski equation. These solutions were not sonicated at any
point.
Embryonic Zebrafish Waterborne Exposure to AuNPs. The chorion,
or acellular envelope surrounding embryonic zebrafish, was
enzymaticallyremovedfrom embryosat6hpostfertilization. At
8 hpf, embryos were individually exposed in wells of a 96-well
plate to 100 μL of nanomaterial solution. Embryos were eval-
uated at 24 hpf for viability, developmental progression, and
spontaneous movements (earliest behavior in zebrafish). At
120hpf,larvalmorphology(bodyaxis,eye,snout,jaw,oticvesicle,
notochord, heart, brain, somite, fin, yolk sac, trunk, circulation,
pigment, swim bladder) was binary scored (present or absent)
and behavioral end points (motility, tactile response) were thor-
oughly evaluated in vivo. A detailed descriptionofthe methodol-
ogy used can be found in Troung et al.
55 The research protocols
andproceduresinvolvingzebrafishwerereviewedand approved
by the Oregon State University Institutional Animal Care and Use
Committee, internal protocol number 3903.
Quantification of AuNPs by INAA. Embryos were extensively
washed before AuNPs were quantified by INNA to minimize
inclusion of particles that were merely stuck to the exterior of
the embryo rather than internalized. Embryos were placed in a
Petri dish and rinsed three times with 15 mL of fish water, with
the excess being allowed to flow into a waste container.
Individual embryos were encapsulated and ﬂooded with
neutrons (generated by a nuclear reactor) to activate or create
radioactiveisotopesoftheelementspresent.Bymonitoringthe
subsequent decay of these radioactive nuclei, it was possible to
identify and precisely quantify the elements originally present
in the sample. Instrument neutron activation analysis oﬀers a
very sensitive technique for detecting metals in biological
samples and is especially sensitive to the presence of gold.
19,56
AnalyticaccuracyandprecisionarehighwithINAA,withamean
errorof<2%maintainedoverseveralordersofmagnitude,from
metal concentrations in the ppb to low percent range. For each
triplicate of samples prepared for INAA, a separate sample vial
containing 40 mL of the exposure solution was prepared to
quantify total amount of gold exposure. Uptake rates were
calculated by dividing the quantity of gold (ng) by the hours of
exposure minus the quantity of gold (ng) observed in the prior
exposure period.
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